Cogent Biosciences, Inc. (COGT)
36.12
-0.75
(-2.03%)
USD |
NASDAQ |
Mar 27, 16:00
36.12
0.00 (0.00%)
After-Hours: 18:25
Cogent Biosciences Cash from Investing (Quarterly) : -322.77M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Terns Pharmaceuticals, Inc. | 24.50M |
| Nuvalent, Inc. | -280.94M |
| Sarepta Therapeutics, Inc. | 96.21M |
| BridgeBio Pharma, Inc. | -13.75M |
| Mirum Pharmaceuticals, Inc. | 1.006M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -79.10M |
| Cash from Financing (Quarterly) | 588.67M |
| Free Cash Flow | -266.00M |
| Free Cash Flow Per Share (Quarterly) | -0.5406 |
| Free Cash Flow to Equity (Quarterly) | -258.15M |
| Free Cash Flow to Firm (Quarterly) | -78.63M |
| Free Cash Flow Yield | -5.74% |